Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Front Immunol. 2023 Apr 25:14:1201033. doi: 10.3389/fimmu.2023.1201033. eCollection 2023.

Nicole E Skinner^{1

2}, Clinton O Ogega³, Nicole Frumento³, Kaitlyn E Clark³, Harry Paul³, Srinivasan Yegnasubramanian⁴, Kornel Schuebel⁴, Jennifer Meyers⁴, Anuj Gupta⁴, Sarah Wheelan⁴, Andrea L Cox^{3

4}, James E Crowe Jr^{5

6

7}, Stuart C Ray^{3

4}, Justin R Bailey³

¹ Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.
² Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.
³ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
⁴ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
⁵ Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
⁶ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
⁷ Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1135841.].

Keywords: B cell; B cell receptor; hepatitis C virus; neutralizing antibody; vaccine.